These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10869738)

  • 1. The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups.
    Vrieling C; Collette L; Fourquet A; Hoogenraad WJ; Horiot JH; Jager JJ; Pierart M; Poortmans PM; Struikmans H; Maat B; Van Limbergen E; Bartelink H
    Radiother Oncol; 2000 Jun; 55(3):219-32. PubMed ID: 10869738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer.
    Vrieling C; Collette L; Fourquet A; Hoogenraad WJ; Horiot JC; Jager JJ; Pierart M; Poortmans PM; Struikmans H; Van der Hulst M; Van der Schueren E; Bartelink H
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):677-85. PubMed ID: 10524422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the methods of cosmetic assessment after breast-conserving therapy in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer.
    Vrieling C; Collette L; Bartelink E; Borger JH; Brenninkmeyer SJ; Horiot JC; Pierart M; Poortmans PM; Struikmans H; Van der Schueren E; Van Dongen JA; Van Limbergen E; Bartelink H
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):667-76. PubMed ID: 10524421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposal for a gold standard for cosmetic evaluation after breast conserving therapy: Results from the St George and Wollongong Breast Boost trial.
    Merie R; Browne L; Cardoso JS; Cardoso MJ; Chin Y; Clark C; Graham P; Szwajcer A; Hau E
    J Med Imaging Radiat Oncol; 2017 Dec; 61(6):819-825. PubMed ID: 28834326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC Trial 10801. The European Organization for Research and Treatment of Cancer (EORTC), Breast Cancer Co-operative Group (BCCG).
    Curran D; van Dongen JP; Aaronson NK; Kiebert G; Fentiman IS; Mignolet F; Bartelink H
    Eur J Cancer; 1998 Feb; 34(3):307-14. PubMed ID: 9640214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors for poor cosmetic outcome in patients with early stage breast cancer treated with breast conserving therapy: Results of the Young boost trial.
    Brouwers PJAM; van Werkhoven E; Bartelink H; Fourquet A; Lemanski C; van Loon J; Maduro JH; Russell NS; Scheijmans LJEE; Schinagl DAX; Westenberg AH; Poortmans P; Boersma LJ;
    Radiother Oncol; 2018 Sep; 128(3):434-441. PubMed ID: 29980320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term cosmetic outcome after preoperative radio-/chemotherapy in locally advanced breast cancer patients.
    Matuschek C; Nestle-Kraemling C; Haussmann J; Bölke E; Wollandt S; Speer V; Djiepmo Njanang FJ; Tamaskovics B; Gerber PA; Orth K; Ruckhaeberle E; Fehm T; Corradini S; Lammering G; Mohrmann S; Audretsch W; Roth S; Kammers K; Budach W
    Strahlenther Onkol; 2019 Jul; 195(7):615-628. PubMed ID: 31101954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cosmetic results and complications after breast conserving therapy for early breast cancer.
    Fujishiro S; Mitsumori M; Kokubo M; Nagata Y; Sasai K; Mise K; Kodama H; Hiroka M
    Breast Cancer; 2000 Jan; 7(1):57-63. PubMed ID: 11029772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cosmetic evaluation of breast conserving treatment for mammary cancer. 2. A quantitative analysis of the influence of radiation dose, fractionation schedules and surgical treatment techniques on cosmetic results.
    Van Limbergen E; Rijnders A; van der Schueren E; Lerut T; Christiaens R
    Radiother Oncol; 1989 Dec; 16(4):253-67. PubMed ID: 2616812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing cosmetic results after conservation therapy for breast cancer.
    Taylor ME; Perez CA; Halverson KJ; Kuske RR; Philpott GW; Garcia DM; Mortimer JE; Myerson RJ; Radford D; Rush C
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):753-64. PubMed ID: 7860386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
    Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
    Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cosmetic evaluation of breast cancer treatment: a randomized study of radiotherapy boost technique.
    Vass S; Bairati I
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1274-82. PubMed ID: 16029782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late skin and subcutaneous soft tissue changes after 10-gy boost for breast conserving therapy.
    Okumura S; Mitsumori M; Kokubo M; Yamauchi C; Kawamura S; Oya N; Nagata Y; Hiraoka M
    Breast Cancer; 2003; 10(2):129-33. PubMed ID: 12736565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer.
    Touboul E; Buffat L; Lefranc JP; Blondon J; Deniaud E; Mammar H; Laugier A; Schlienger M
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1019-28. PubMed ID: 8600084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast-specific factors determine cosmetic outcome and patient satisfaction after breast-conserving therapy: Results from the randomized COBALT study.
    Volders JH; Negenborn VL; Haloua MH; Krekel NMA; Jóźwiak K; Meijer S; van den Tol PM
    J Surg Oncol; 2018 Apr; 117(5):1001-1008. PubMed ID: 29473960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does cosmetic outcome from treatment of primary breast cancer influence psychosocial morbidity?
    Al-Ghazal SK; Fallowfield L; Blamey RW
    Eur J Surg Oncol; 1999 Dec; 25(6):571-3. PubMed ID: 10556001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of simultaneous integrated boost, hypofractionation and oncoplastic surgery on cosmetic outcome and PROMs after breast conserving therapy.
    Lansu JT; Essers M; Voogd AC; Luiten EJ; Buijs C; Groenendaal N; Poortmans PM
    Eur J Surg Oncol; 2015 Oct; 41(10):1411-6. PubMed ID: 26260375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and cosmetic results of breast boost radiotherapy in early breast cancer: a randomized study between electron and photon.
    Rajan SS; Sharma SC; Kumar N; Kumar R; Singh G; Singh R; Tomar P
    J Cancer Res Ther; 2014; 10(4):889-95. PubMed ID: 25579524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cosmesis, late sequelae and local control after breast-conserving therapy: influence of type of tumour bed boost and adjuvant chemotherapy.
    Budrukkar AN; Sarin R; Shrivastava SK; Deshpande DD; Dinshaw KA
    Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):596-603. PubMed ID: 17706403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.